The potential of ingestible sensors combined with family involvement interventions for medication supervision in Tuberculosis patients: A literature review
DOI:
https://doi.org/10.61511/phraj.v2i2.2025.1516Keywords:
family involvement intervention, ingestible sensor, Tuberculosis [MeSH]Abstract
Background: Tuberculosis (TB) is an airborne infectious disease that remains the second leading cause of death from infectious diseases globally. A major challenge in eliminating TB, despite it being preventable and curable, is the low adherence to treatment. This literature review aims to provide insights into the potential of ingestible sensors combined with family involvement interventions for medication supervision in TB patients, ensuring that medications are actually swallowed and addressing a key limitation of the previous DOT method. Methods: This study used a literature review method with the keywords "family engagement intervention", "digestible sensor", and "tuberculosis [MeSH]" to search databases such as Google Scholar, Science Direct, ResearchGate, and NCBI. Inclusion criteria included in vitro and in vivo experimental studies, cohort studies, comparative analysis studies, and reviews published in the last 10 years. Exclusion criteria included incomplete studies, inaccessible papers, and non-English/Indonesian texts. After applying these criteria, 35 journals and 1 book were selected for review and analysis. Findings: Ingestible sensors have shown over 80% effectiveness in monitoring medication adherence by providing real-time data for precise treatment adjustments. When combined with family involvement, these interventions address psychosocial barriers like stigma and lack of support, further improving adherence. This synergy significantly reduces non-compliance, prevents drug resistance, and enhances treatment outcomes for TB patients. Conclusion: Ingestible sensors combined with family involvement offer a more effective approach to TB treatment by ensuring medication is swallowed and providing psychosocial support, reducing risks of transmission, relapse, and drug resistance. However, equitable access and adequate infrastructure, supported by government and societal cooperation, are crucial for the successful implementation of this system globally. Novelty/Originality of this article: This study explores the innovative use of ingestible sensors combined with family involvement to improve TB treatment adherence, offering a novel contribution to TB management.
References
Adinda Nezma Meidina, Putri, Y. D., Akbar Triandra, Muhammad Valdis Muyassar, Fajri, A., Dyah Fatha Istiqomah, Nabila Az-zahra Hasibuan, M. Aditya Nugraha, Qonita, R., & Nafilah Ramadhanti. (2024). Unveiling TB. Asadel Publisher.
Alipour, A., Gabrielson, S., & Patel, P. B. (2020). Ingestible Sensors and Medication Adherence: Focus on Use in Serious Mental Illness. Pharmacy, 8(2), 103. https://doi.org/10.3390/pharmacy8020103
Alsayed, S. S. R., & Gunosewoyo, H. (2023). TB: Pathogenesis, Current Treatment Regimens and New Drug Targets. International Journal of Molecular Sciences, 24(6), 5202. https://doi.org/10.3390/ijms24065202
Anastasiia Diatlova, Linkova, N., Lavrova, A., Yulia Zinchenko, Medvedev, D., Alexandr Krasichkov, Polyakova, V., & Piotr Yablonskiy. (2023). Molecular Markers of Early Immune Response in TB: Prospects of Application in Predictive Medicine. International Journal of Molecular Sciences, 24(17), 13261–13261. https://doi.org/10.3390/ijms241713261
Aranas, L., Alam, K., Gyawali, P., & Alam, R. M. (2023). Drug-resistant tuberculosis stigma among healthcare workers toward the development of a stigma-reduction strategy: A scoping review. INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 60. https://doi.org/10.1177/00469580231180754
Aremu, T. O., Oluwole, O. E., Adeyinka, K. O., & Schommer, J. C. (2022). Medication adherence and compliance: Recipe for improving patient outcomes. Pharmacy, 10(5). https://doi.org/10.3390/pharmacy10050106
Baumgartner, S. L., Buffkin Jr, D. E., Rukavina, E., Jones, J., Weiler, E., & Carnes, T. C. (2021). A Novel Digital Pill System for Medication Adherence Measurement and Reporting: Usability Validation Study. JMIR Human Factors, 8(4), e30786. https://doi.org/10.2196/30786
Browne, S., Umlauf, A., Moore, D. J., Benson, C. A., & Vaida, F. (2024). User Experience of Persons Using Ingestible Sensor–Enabled Pre-Exposure Prophylaxis to Prevent HIV Infection: Cross-Sectional Survey Study. JMIR Mhealth and Uhealth, 12, e53596–e53596. https://doi.org/10.2196/53596
Carr, W., Kurbatova, E., Starks, A., Goswami, N., Allen, L., & Winston, C. (2022). Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary TB — United States, 2022. MMWR. Morbidity and Mortality Weekly Report, 71(8), 285–289. https://doi.org/10.15585/mmwr.mm7108a1
Centers for Disease Control and Prevention. (2023). Treatment for TB Disease. U.S. Centers For Disease Control and Prevention. https://www.cdc.gov/tb/topic/treatment/tbdisease.htm
Centers for Disease Control and Prevention. (2024). Treating TB Using Video Directly Observed Therapy. U.S. Centers For Disease Control and Prevention. https://www.cdc.gov/tb/hcp/treatment/vdot.html
Chai, P. R., Goodman, G., Bustamante, M. J., Mohamed, Y., Castillo-Mancilla, J., Boyer, E. W., Mayer, K. H., Rosen, R. K., Baumgartner, S. L., Buffkin, E., & O’Cleirigh, C. (2021). Long-Term Stability of the Electronic Sensor Component of a Digital Pill System in Real-World Storage Settings. Journal of Pharmacy Technology, 875512252098521. https://doi.org/10.1177/8755122520985219
Chen, X., Du, L., Wu, R., Xu, J., Ji, H., Zhang, Y., Zhu, X., & Zhou, L. (2020). The effects of family, society and national policy support on treatment adherence among newly diagnosed TB patients: a cross-sectional study. BMC Infectious Diseases, 20(1). https://doi.org/10.1186/s12879-020-05354-3
Coleman, M., Martinez, L., Theron, G., Wood, R., & Marais, B. (2022). Mycobacterium TB Transmission in High-Incidence Settings—New Paradigms and Insights. Pathogens, 11(11), 1228. https://doi.org/10.3390/pathogens11111228
Dartois, V. A., & Rubin, E. J. (2022). Anti-TB treatment strategies and drug development: Challenges and priorities. Nature Reviews Microbiology, 20, 685–701. https://doi.org/10.1038/s41579-022-00731-y
De la Paz, E., Maganti, N. H., Trifonov, A., Jeerapan, I., Mahato, K., Yin, L., Sonsa-ard, T., Ma, N., Jung, W., Burns, R., Zarrinpar, A., Wang, J., & Mercier, P. P. (2022). A self-powered ingestible wireless biosensing system for real-time in situ monitoring of gastrointestinal tract metabolites. Nature Communications, 13(1), 7405. https://doi.org/10.1038/s41467-022-35074-y
FDA. (2018). FDA approves pill with sensor that digitally tracks if patients have ingested their medication. FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-pill-sensor-digitally-tracks-if-patients-have-ingested-their-medication
Fuady, A., Arifin, B., Yunita, F., Rauf, S., Fitriangga, A., et al. (2024). Stigma, depression, quality of life, and the need for psychosocial support among people with tuberculosis in Indonesia: A multi-site cross-sectional study. PLOS Global Public Health, 4(1), e0002489. https://doi.org/10.1371/journal.pgph.0002489
Garfein, R. S., & Doshi, R. P. (2019). Synchronous and asynchronous video observed therapy (VOT) for TB treatment adherence monitoring and support. Journal of Clinical TB and Other Mycobacterial Diseases, 17, 100098. https://doi.org/10.1016/j.jctube.2019.100098
Goodman, G. R., Vaz, C., Albrechta, H., Boyer, E. W., Mayer, K. H., O’Cleirigh, C., & Chai, P. R. (2022). Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy. Current HIV/AIDS Reports, 19(5), 433–445. https://doi.org/10.1007/s11904-022-00625-x
Grace Florita Pasaribu, Myrnawati Crie Handini, Jasmen Manurung, Kesaktian Manurung, Rinawati Sembiring, & Mindo Tua Siagian. (2023). Ketidakpatuhan minum obat pada pasien TB paru: Studi kualitatif. Jurnal Prima Medika Sains, 5(1), 48–56. https://doi.org/10.34012/jpms.v5i1.3788
Hafezi, H., Robertson, T. L., Moon, G. D., Au-Yeung, K.-Y., Zdeblick, M. J., & Savage, G. M. (2015). An Ingestible Sensor for Measuring Medication Adherence. IEEE Transactions on Biomedical Engineering, 62(1), 99–109. https://doi.org/10.1109/tbme.2014.2341272
Litvinova, O., Klager, E., Tzvetkov, N. T., Kimberger, O., Kletecka-Pulker, M., Willschke, H., & Atanasov, A. G. (2022). Digital Pills with Ingestible Sensors: Patent Landscape Analysis. Pharmaceuticals, 15(8), 1025. https://doi.org/10.3390/ph15081025
Litvinova, O., Klager, E., Yeung, A. W. K., Tzvetkov, N. T., Kimberger, O., Kletecka-Pulker, M., Willschke, H., & Atanasov, A. G. (2023). Bibliometric analysis and evidence of clinical efficacy and safety of digital pills. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1023250
Liu, H., Wang, Y., Huang, Y., Xiong, D., Shen, J., Siqueiros, L., Bala, V., Savage, G. M., Guerrero, M., Corado, K., Rosen, M. I., Fletcher, C. V., & Daar, E. S. (2022). Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial. EBioMedicine, 86, 104330–104330. https://doi.org/10.1016/j.ebiom.2022.104330
Mangan, J. M. (2023). Recommendations for Use of Video Directly Observed Therapy During TB Treatment — United States, 2023. Morbidity and Mortality Weekly Report, 72(12). https://doi.org/10.15585/mmwr.mm7212a4
Manjula T., Nirosha C., Nandhini D., Kokila M., & Revathi V. (2024). An Comprehensive Review Of Ingestible Sensors. International Journal of Pharmaceutical Sciences, 2(8), 3224-3229. https://doi.org/10.5281/zenodo.13333392
Matteelli, A., & Alffenaar, J.-W. C. (2022). Diagnosis and treatment of TB infection: can it contribute to achieving TB elimination? European Respiratory Journal, 60(1), 2200540. https://doi.org/10.1183/13993003.00540-2022
Richey, A., Kovacs, I., & Browne, S. (2022). Viewpoint Use of an Ingestible Sensor-based Digital Adherence System to Strengthen the Therapeutic Relationship in Serious Mental Illness. (Preprint). JMIR Mental Health. https://doi.org/10.2196/39047
Ridho, A., Alfian, S. D., van Boven, J., Levita, J., Aki Yalcin, E., Le, L., Alffenaar, J.-W., Hak, E., Abdulah, R., & Pradipta, I. S. (2021). Digital health technologies to improve medication adherence and treatment outcomes in TB patients: A systematic review of randomized controlled studies (preprint). Journal of Medical Internet Research, 24(2). https://doi.org/10.2196/33062
Sazali, M. F., Rahim, S. S. S. A., Mohammad, A. H., Kadir, F., Payus, A. O., Avoi, R., Jeffree, M. S., Omar, A., Ibrahim, M. Y., Atil, A., Tuah, N. M., Dapari, R., Lansing, M. G., Rahim, A. A. A., & Azhar, Z. I. (2022). Improving TB medication adherence: The potential of integrating digital technology and health belief model. TB and Respiratory Diseases, 86(2). https://doi.org/10.4046/trd.2022.0148
Thomas, B. E., & Stephen, A. (2020). TB related stigma in India: roadblocks and the way forward. Expert Review of Respiratory Medicine, 15(7), 1–3. https://doi.org/10.1080/17476348.2020.1826314
Vaz, C., Jose, N. K., Jeremiah Jacob Tom, Goodman, G. R., Lee, J. S., Rana Prathap Padappayil, Manjunath Madathil, Conall O’Cleirigh, Rodrigues, R., & Chai, P. R. (2022). Formative acceptance of ingestible biosensors to measure adherence to TB medications. BMC Infectious Diseases, 22(1). https://doi.org/10.1186/s12879-022-07756-x
Yin, J., Wang, X., Zhou, L., & Wei, X. (2018). The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant TB in China: a mixed-methods study. Tropical Medicine & International Health, 23(6), 668–677. https://doi.org/10.1111/tmi.13066
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2025 Adinda Nezma Meidina, Nafilah Ramadhanti, M. Aidil Tarensyah Riza, Zelka Dapala, M. Daffa Fareza
This work is licensed under a Creative Commons Attribution 4.0 International License.
